Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anna Surus-Hyla"'
Autor:
Bozena Cybulska-Stopa, Anna Malgorzata Czarnecka, Krzysztof Ostaszewski, Karolina Piejko, Marcin Zietek, Robert Dziura, Ewa Rutkowska, Łukasz Galus, Barbara Ziolkowska, Natasza Kempa-Kamińska, Joanna Seredyńska, Agnieszka Kamycka, Wieslaw Bal, Anna Surus-Hyla, Tomasz Switaj, Pawel Rogala, Grazyna Kaminska-Winciorek, Rafał Suwiński, Jacek Mackiewicz, Piotr Rutkowski
Publikováno v:
Journal of Clinical Oncology. 40:e21539-e21539
e21539 Background: The use of targeted therapies (TT) and checkpoint inhibitors (IT) significantly prolonged survival in patients with metastatic melanoma, especially in patients with BRAF mutation-positive melanoma. Optimal sequence of therapies use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0821bf030f85619f460aa933100a4abe
https://doi.org/10.1200/jco.2022.40.16_suppl.e21539
https://doi.org/10.1200/jco.2022.40.16_suppl.e21539
Autor:
Paweł Rogala, Anna M. Czarnecka, Bożena Cybulska-Stopa, Krzysztof Ostaszewski, Karolina Piejko, Marcin Ziętek, Robert Dziura, Ewa Rutkowska, Łukasz Galus, Natasza Kempa-Kamińska, Joanna Seredyńska, Wiesław Bal, Katarzyna Kozak, Anna Surus-Hyla, Tomasz Kubiatowski, Grażyna Kamińska-Winciorek, Rafał Suwiński, Jacek Mackiewicz, Piotr Rutkowski
Publikováno v:
Cancers; Volume 14; Issue 9; Pages: 2123
(1) Background: BRAFi/MEKi are usually offered as a first line treatment for patients requiring rapid response; with elevated lactate dehydrogenase (LDH) activity, large tumor burden, and with brain metastases. The efficacy of second line therapies a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb327cdf124fb0575450d1bb6d137c0c
https://doi.org/10.3390/cancers14092123
https://doi.org/10.3390/cancers14092123
Autor:
Katarzyna Sosińska-Mielcarek, Wojciech Biernat, Małgorzata Kowalska, Ewa Chmielowska, Aleksandra Pfeifer, Janusz Patera, Ewa Kalinka-Warzocha, Anton Żawrocki, Rafal Matkowski, Jadwiga Żebracka-Gala, Jacek Jassem, Sylwia Szablowska-Siwik, Antonino Musolino, Anna Surus-Hyla, Bożenna Karczmarek-Borowska, Anna Kowalczyk, Agnieszka Pliszka, Malgorzata Oczko-Wojciechowska, Małgorzata Foszczyńska-Kłoda, Renata Duchnowska, Sylwia Dębska-Szmich, Wojciech P. Olszewski, Maria Litwiniuk, Dagmara Rusinek, Michał Jarząb, Tomasz Tyszkiewicz, Bogumiła Czartoryska-Arłukowicz, Beata Głodek-Sutek, Barbara Radecka
Publikováno v:
Clinical breast cancer. 17(2)
Triple-negative breast cancer (TNBC) lacks expression of steroid hormone receptors (estrogen receptor α and progesterone) and epidermal growth factor receptor type 2. This phenotype shows high metastatic potential, with particular predilection to lu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eac0d56f6f027882ad403e9ff176bba1
https://pubmed.ncbi.nlm.nih.gov/27692773
https://pubmed.ncbi.nlm.nih.gov/27692773